Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small fraction of patients. Many tumors develop resistance or evade immune detection through genetic and…
Neoantigens-loaded DC vaccines show strong potential to overcome tumor resistance
